International Journal of Drug Policy
Volume 16, Supplement 1 , Pages 7-20, December 2005

Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions

  • Gerry V. Stimson

      Affiliations

    • Department of Primary Care and Social Medicine, The Centre for Research on Drugs and Health Behaviour, Imperial College, The Reynolds Building, St Dunstan's Road, London W6 8RP, UK
    • International Harm Reduction Association, PO Box 818, North Melbourne 3051, Melbourne, Vic., Australia
    • Corresponding Author InformationCorresponding author. Tel.: +44 20 7594 0776; fax: +44 20 7594 0852.
  • ,
  • Matthew Hickman

      Affiliations

    • Department of Primary Care and Social Medicine, The Centre for Research on Drugs and Health Behaviour, Imperial College, The Reynolds Building, St Dunstan's Road, London W6 8RP, UK
  • ,
  • Tim Rhodes

      Affiliations

    • Department of Primary Care and Social Medicine, The Centre for Research on Drugs and Health Behaviour, Imperial College, The Reynolds Building, St Dunstan's Road, London W6 8RP, UK
  • ,
  • Francisco Bastos

      Affiliations

    • Owaldo Cruz Foundation, Av. Brasil, 4365, Biblioteca de Manguinhos #229, 21045-900 Rio de Janeiro, Brazil
  • ,
  • Tobi Saidel

      Affiliations

    • Family Health International, Asia Regional Office, Arwan Building, 8th Floor, 1339 Pracharat 1 Road, Bangsue, Bangkok 10800, Thailand

Received 11 January 2005; received in revised form 4 February 2005; accepted 6 February 2005.

Abstract 

A wide range of methods is now available for assessing the nature and characteristics of drug injecting populations, and for evaluating the effectiveness of interventions developed to reduce injecting related harms. The public health surveillance tasks in relation to injecting drug use populations and associated health problems are the same, in principle, as for the surveillance of other health problems. These are: to describe the patterns of the condition, the nature of the problem and the environment (context) in which it occurs; to determine the scale of interventions needed and estimated coverage required, to forecast future health care needs; to mobilise resources and target prevention; and to evaluate interventions. Countries vary in their existing levels of information as well as resources for surveillance systems, research and evaluation. We propose three levels of assessment: basic assessment, which is suitable in situations of low awareness and information, routine surveillance, and enhanced surveillance, which requires more complex research and/or analyses of data collected from routine surveillance.

Keywords: Assessment, Injecting drug use, HIV, Research, Public health surveillance, Evaluation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(05)00083-6

doi:10.1016/j.drugpo.2005.02.007

International Journal of Drug Policy
Volume 16, Supplement 1 , Pages 7-20, December 2005